life sciences

Life Science REIT halves dividend payout amid 'macroeconomic uncertainty'

2p from 4p in 2022

26 March 2024 • 2 min read

Partner Insight: I&I therapies hit new milestones for patients and investors

Portfolio Managers Andy Acker and Agustin Mohedas explain why shares of companies delivering next-generation therapies for inflammation and immunology (I&I) disorders could have plenty of room to run.

26 October 2023 • 8 min read

Investment Trusts

Syncona launches £40m share buyback programme

40% discount to NAV

29 September 2023 • 2 min read

Investment Trusts

Life Science REIT IPO aims to raise £300m after lining up £445m investment pipeline

Ironstone Asset Management named investment adviser

19 October 2021 • 2 min read

Specialist

Six big life science trends investors must watch for

Developments in healthcare provision and technology

24 July 2019 • 1 min read

Investment Trusts

Two alternatives to the trusts on eye-watering premiums

Enthusiasm can sometimes get the better of all of us. Investors always find ways to justify prices for companies at any stage in the cycle, writes William Heathcoat-Amory, partner at Kepler Trust Intelligence.

29 August 2018 • 4 min read

Thousands of Woodford investors join RGL lawsuit against Hargreaves Lansdown

18 November 2024 • 1 min read

Legal & General to cut jobs in revamped asset management arm

18 November 2024 • 1 min read

ETF providers launch unlisted share classes to address slow adoption in fast-growing MPS market

22 November 2024 • 5 min read

Investment Week reveals winners of Investment Company of the Year Awards 2024

22 November 2024 • 3 min read

Baillie Gifford withdraws from Climate Action 100+ and Net Zero Asset Managers initiative

18 November 2024 • 1 min read